Germany Joins Ban of Bayer Herbicide -- WSJ
September 05 2019 - 3:02AM
Dow Jones News
By Ruth Bender
This article is being republished as part of our daily
reproduction of WSJ.com articles that also appeared in the U.S.
print edition of The Wall Street Journal (September 5, 2019).
BERLIN -- Bayer AG's efforts to fend off thousands of lawsuits
against its Roundup herbicide were dealt a symbolic blow Wednesday
when Germany, the company's home country, said it would ban the
product's key ingredient.
The move is unlikely to directly affect the chemicals and
pharmaceuticals group's bottom line because Germany is a negligibly
small market for Roundup. The decision was motivated by
environmental considerations rather than glyphosate's alleged
potential to cause cancer, which is at the center of the lawsuits.
Still, the optics of Roundup being banned in Bayer's backyard are
jarring amid the company's insistence that it is safe to use.
After Bayer acquired Roundup inventor Monsanto Co. in 2018, the
German company was hit by lawsuits from 18,400 farmers, hobby
gardeners and others who said Roundup made them ill. The company,
which is appealing the verdicts, has pointed to the scores of
markets where glyphosate is licensed as evidence of its safety.
Germany, where Bayer was founded and is based, has approved a
plan to gradually restrict the use of glyphosate, the main
ingredient in Roundup, and ban it outright as of the end of 2023,
shortly after a Europe-wide license for the chemical expires.
The head of Bayer's crop-science business, which now includes
Monsanto, said the company disagreed with the move to a unilateral
ban.
"The ruling ignores decades of scientific judgment from
independent regulatory agencies around the world that glyphosate is
safe when used properly," Liam Condon said.
The ban would have very little impact on Bayer's sales, analysts
said. Bayer says Europe accounts for less than 10% of its total
glyphosate sales, which the company doesn't break out. The bulk of
glyphosate sales are generated in the U.S. and South America.
Bayer said pro forma crop-science sales reached EUR19.3 billion
($21.2 billion) in 2018. The figure assumes Monsanto had been part
of the business for the entire year and not just since June 7,
2018, when the acquisition closed.
The planned ban highlights the growing resistance to glyphosate
in Europe, which could lead European Union countries to oppose
another bloc-wide license in late 2022 when they are due to vote on
a renewal.
In July, Austria became the first European country to impose a
ban on glyphosate. In France, a court banned a Roundup brand
earlier this year, while some mayors this summer moved to ban
glyphosate in their municipalities.
The topic has split the EU for years. In 2017, a new five-year
license was almost voted down until a last-minute nod from Germany
tipped the balance. The surprise decision, made by the agriculture
minister against the advice of the rest of the government, sparked
an uproar in the country.
Other countries outside Europe have adopted total and partial
glyphosate bans in the past, such as Colombia and El Salvador. Sri
Lanka in 2015 was the first country to issue a national ban, but
later revoked it.
Before glyphosate is banned outright, Germany will push to
gradually reduce its use, first banning it in gardens and parks and
imposing stricter rules for its use in agriculture.
Write to Ruth Bender at Ruth.Bender@wsj.com
(END) Dow Jones Newswires
September 05, 2019 02:47 ET (06:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2023 to Apr 2024